Glaxosmithkline has been present in Turkey for more than 50 years, and today is the sixth largest vendor of pharmaceutical products in the country. Istanbul has served as a hub for the pharmaceutical division in the MENA-CIS region since 2012, with a regional-level staff of 30 people of various nationalities; the consumer health division regional HQ will be moved to Turkey by the end of Q1 2016. Overall, GSK Turkey employs over 800 people across pharmaceuticals and consumer health business units.
GSK has made several large investments in the Turkish market, including the only Vaccine Clinical Research Center (AKAM) in Turkey, established in 2010 in Ankara. Over USD 21.5 million has been invested thus far in partnership with a CMO partner for the production of five different antigens, targeting a local production of 33 million doses per year, and two of these will be produced beginning at the formulation level.
Within pharmaceuticals, GSK Turkey has three main business units; respiratory, classical brands and vaccines and critical diseases. Major brands by unit and team include;
GSK Turkey will launch 9 new products from the pipeline between 2016 and 2019.
Contact Details
Büyükdere Cad. 1. Levent Plaza No:173 B Blok
34394 Levent İstanbul
(0212) 339 44 00 – 339 45 75
GSK Türkiye Call Center: 444 5 GSK (444 5 475)
Selim Giray, the recently appointed VP and general manager of GSK Turkey, provides insights into the company’s eye-catching footprint and commitment to Turkey, his ambition to integrate into the market’s…
GSK’s VP and Area GM Pharmaceuticals, Turkey and Caucasus, and chairman of Turkey’s innovative pharmaceutical association, discusses the effectiveness of the government’s current strategy for reducing the trade deficit in…
Mr Fadıllıoğlu, after a previous position at Abbott, you were recently appointed head of GSK Turkey. How different is GSK as an organization? What new therapeutic areas, processes, or corporate…
Ismail Yormaz, vice president & regional director south-east at Recordati, shares the management secrets that have helped him grow Recordati into one of the top pharma companies in Turkey. He…
Sule Mene, co-founder, president and CEO of Mene Health Group, shares with PharmaBoardroom the journey of her company starting as the first government-approved CRO of Turkey, its parallel growth alongside…
Tuğçe Koç reveals how Onko Koçsel was able to quickly grow from an in-licenser to a production-oriented pharmaceutical company with an international reach. She also offers her take on how…
Kazim Dinç, chairman of the board of SURDER and former Minister of Health of Turkey, offers his insights into the Turkish OTC and health products market, highlighting the challenges facing…
Despite the sharp decline in the Turkish lira’s value, the general mood among pharmaceutical executives in Turkey is positive. Rather than being discouraged, they are calling upon their resiliency and…
Acibadem’s Mehmet Ali Aydınlar offers his insights into the Turkish healthcare sector, highlighting Turkey’s burgeoning healthcare tourism industry. He also describes Acıbadem’s focus of growth, globalization and fundamental values that…
Murat Kavrar, country manager at Ekol Turkey, offers readers a look at Ekol’s innovative approach to the logistics sector, emphasizing his company’s R&D capacity and eco-friendly solutions that provide client…
With the construction of state-of-the-art public and private hospitals, Turkey is poised to become a global leader in medical tourism. Turkey has always been a popular tourist destination, given…
Abidin Gulmus, founder and chairman of Gen Ilaç, describes the company’s impressive journey to become Turkey’s principle orphan drug distributor and shares his vision for leveraging the company’s domestic expertise…
In 2016 the Turkish Medicine and Medical Devices Agency (TiTCK) implemented a localisation policy to reduce Turkey’s reliance on imports – a few years later, it has created a young,…
Massimo d’Eufemia, head representative of the European Investment Bank (EIB) in Turkey, highlights the importance of Turkey for the EIB and how the country’s geographic position and key economic role…
Tahsin Yüksel, general manager of Teva Turkey, analyzes the strategic importance of pharmaceutical branding in Turkey, shares the story of Teva’s adaptation to the unique market needs, and offers his…
See our Cookie Privacy Policy Here
